
Swiss public CDMO (PPGN.SX). Founded 1952, headquartered in Baar, Switzerland. Operates 6 GMP facilities in Sweden, Belgium, France, USA, and India. Specializes in peptide and oligonucleotide APIs. Claims to manufacture ~50% of commercially approved peptide APIs globally. Provides robust global shipping network supporting pharmaceutical supply chains.
Claim this listing to update your information, respond to buyer inquiries, and get a verified badge.
Free to claim. Verified upgrades available.